156 related articles for article (PubMed ID: 27469927)
1. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.
Hu FZ; Sheng ZZ; Qin CP; Xu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927
[TBL] [Abstract][Full Text] [Related]
2. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
[TBL] [Abstract][Full Text] [Related]
3. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
[TBL] [Abstract][Full Text] [Related]
4. Characterization and expression profile of CMTM3/CKLFSF3.
Zhong J; Wang Y; Qiu X; Mo X; Liu Y; Li T; Song Q; Ma D; Han W
J Biochem Mol Biol; 2006 Sep; 39(5):537-45. PubMed ID: 17002874
[TBL] [Abstract][Full Text] [Related]
5. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):594-597. PubMed ID: 29263495
[TBL] [Abstract][Full Text] [Related]
6. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
Li W; Zhang S
Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
[TBL] [Abstract][Full Text] [Related]
7. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
8. Research Advances in Chemokine-like Factor Super Family Member 8.
Gao DH; Hu H; Fang ZW; Huo F; Wang HR; Xu KX; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):746-749. PubMed ID: 28065246
[TBL] [Abstract][Full Text] [Related]
9. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
Su Y; Lin Y; Zhang L; Liu B; Yuan W; Mo X; Wang X; Li H; Xing X; Cheng X; Dong B; Hu Y; Du H; Zhu Y; Ding N; Li J; Liu W; Ma Y; Qiu X; Ji J; Han W
Cancer Sci; 2014 Jan; 105(1):26-34. PubMed ID: 24131472
[TBL] [Abstract][Full Text] [Related]
11. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
Lu M; Huang Y; Sun W; Li P; Li L; Li L
Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
[TBL] [Abstract][Full Text] [Related]
12. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
13. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
Duan HJ; Li XY; Liu C; Deng XL
Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
[TBL] [Abstract][Full Text] [Related]
14. CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.
Xie J; Yuan Y; Liu Z; Xiao Y; Zhang X; Qin C; Sheng Z; Xu T; Wang X
Clin Transl Oncol; 2014 Apr; 16(4):402-9. PubMed ID: 23907292
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
Xie G; Cheng J; Zhang J
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
[TBL] [Abstract][Full Text] [Related]
16. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
17. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
[TBL] [Abstract][Full Text] [Related]
18. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
Duan SL; Jiang Y; Li GQ; Fu W; Song Z; Li LN; Li J
PeerJ; 2024; 12():e16757. PubMed ID: 38223763
[TBL] [Abstract][Full Text] [Related]
19. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
[TBL] [Abstract][Full Text] [Related]
20.
Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
